Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Opioids | Research article

Trends and correlates of driving under the influence of alcohol among different types of adult substance users in the United States: a national survey study

Authors: Ji-Yeun Park, Li-Tzy Wu

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Despite a decrease in driving under the influence of alcohol (DUIA) prevalence over the past decades, DUIA prevalence still remains high in the United States. To date, there is limited research examining whether different types of substance users have different trends in DUIA. This study sought to assess trends and variables associated with DUIA by substance use type.

Methods

National Survey on Drug Use and Health (NSDUH) is a cross-sectional, nationally representative population-based survey. By using the NSDUH 2008–2014, we performed the Joinpoint analysis to identify time trends of DUIA in each group of substance users (aged ≥18 years). Logistic regression analysis was used to explore association between substance use type and DUIA and to identify variables associated with DUIA.

Results

Adults who reported alcohol or drug use in the past year were classified into different groups based on past-year substance use status: alcohol use only (n = 141,521) and drug use regardless alcohol use. Drug users included prescription opioids only (n = 5337), marijuana only (n = 32,206), other single drug (n = 3789), prescription opioids-marijuana (n = 3921), multiple prescription drugs (n = 1267), and other multiple drugs (n = 18,432). The Joinpoint analysis showed that DUIA prevalence decreased significantly from 2008 to 2014 among alcohol only users (Average Annual Percent Change [AAPC] = − 2.8), prescription opioids only users (AAPC = -5.4), marijuana only users (AAPC = -5.0), prescription opioids-marijuana users (AAPC = -6.5), multiple prescription drug users (AAPC = -7.4), and other multiple drug users (AAPC = -3.2). Although the estimate was not statistically significant, other single drug users showed a decreasing trend (AAPC = -0.9). Substance use type was significantly associated with DUIA in the adjusted logistic regression. All drug use groups, relative to the alcohol only group, had elevated odds of DUIA, and the odds were especially elevated for the multiple drug use groups (prescription opioids-marijuana, adjusted odds ratio [AOR] = 2.71; multiple prescription drugs, AOR = 2.83; and other multiple drugs, AOR = 3.68). Additionally, younger age, male sex, being white, higher income, and alcohol abuse/dependence were positively associated with DUIA.

Conclusions

DUIA prevalence decreased over time and the magnitude of this reduction differed by substance use type. DUIA interventions need to be tailored to substance use type and individual characteristics.
Literature
1.
Centers for Disease Control and Prevention. Vital signs: alcohol-impaired driving among adults—United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(39):1351–6.
2.
Lipari RN, Hughes A, Bose J. Driving under the influence of alcohol and illicit drugs. The CBHSQ report: Rockville. In: MD: Substance Abuse and Mental Health Services Administration; 2016.
3.
Hingson R, Zha W, Smyth D. Magnitude and trends in heavy episodic drinking, alcohol-impaired driving, and alcohol-related mortality and overdose hospitalizations among emerging adults of college ages 18-24 in the United States, 1998-2014. J Stud Alcohol Drugs. 2017;78(4):540–8.CrossRefPubMedPubMedCentral
4.
Berning A, Compton R, Wochinger K. Results of the 2013–2014 National Roadside Survey of alcohol and drug use by drivers. (traffic safety facts research note. Report no. DOT HS 812 118). Washington, DC: National Highway Traffic Safety Administration; 2015.
5.
6.
Ahlm K, Björnstig U, Oström M. Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden. Accid Anal Prev. 2009;41(1):129–36.CrossRefPubMed
7.
Mørland J, Steentoft A, Simonsen KW, Ojanperä I, Vuori E, et al. Drugs related to motor vehicle crashes in northern European countries: a study of fatally injured drivers. Accid Anal Prev. 2011;43(6):1920–6.CrossRefPubMed
8.
Taylor B, Rehm J. The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol Clin Exp Res. 2012;36(10):1827–34.CrossRefPubMedPubMedCentral
9.
National Center for. Statistics and analysis. 2016 fatal motor vehicle crashes: overview. (traffic safety facts research note. Report no. DOT HS 812 456). Washington, DC: National Highway Traffic Safety Administration; 2017.
10.
Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010. Am J Epidemiol. 2014;179(6):692–9.CrossRefPubMedPubMedCentral
11.
Blincoe LJ, Miller TR, Zaloshnja E, Lawrence BA. The economic and societal impact of motor vehicle crashes, 2010. (revised) (report no. DOT HS 812 013). Washington, DC: National Highway Traffic Safety Administration; 2015.
12.
Flowers NT, Naimi TS, Brewer RD, Elder RW, Shults RA, et al. Patterns of alcohol consumption and alcohol-impaired driving in the United States. Alcohol Clin Exp Res. 2008;32(4):639–44.CrossRefPubMed
13.
Jewett A, Shults RA, Banerjee T, Bergen G. Alcohol-impaired driving among adults-United States, 2012. MMWR: Morbidity Mortal Wkly Rep. 2015;64(30):814–7.
14.
Quinlan KP, Brewer RD, Siegel P, Sleet DA, Mokdad AH, et al. Alcohol-impaired driving among U.S. adults, 1993-2002. Am J Prev Med. 2005;28(4):346–50.CrossRefPubMed
15.
Schwartz J, Beltz L. Trends in female and male drunken driving prevalence over thirty years: triangulating diverse sources of evidence (1985-2015). Addict Behav. 2018;84:7–12.CrossRefPubMed
16.
McCabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006;67(4):529–37.CrossRefPubMedPubMedCentral
17.
McCabe SE, Veliz P, Patrick ME. High-intensity drinking and nonmedical use of prescription drugs: results from a national survey of 12th grade students. Drug Alcohol Depend. 2017;178:372–9.CrossRefPubMedPubMedCentral
18.
Midanik LT, Tam TW, Weisner C. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007;90(1):72–80.CrossRefPubMedPubMedCentral
19.
Subbaraman MS, Kerr WC. Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey. Alcohol Clin Exp Res. 2015;39(5):872–9.CrossRefPubMedPubMedCentral
20.
Terry-McElrath YM, O'Malley PM, Johnston LD. Simultaneous alcohol and marijuana use among U.S. high school seniors from 1976 to 2011: trends, reasons, and situations. Drug Alcohol Depend. 2013;133(1):71–9.CrossRefPubMedPubMedCentral
21.
McCabe SE, West BT, Teter CJ, Boyd CJ. Co-ingestion of prescription opioids and other drugs among high school seniors: results from a national study. Drug Alcohol Depend. 2012;126(1–2):65–70.CrossRefPubMedPubMedCentral
22.
Ch'ng CW, Fitzgerald M, Gerostamoulos Cameron P, Bui D, Drummer OH, et al. Drug use in motor vehicle drivers presenting to an Australian, adult major trauma Centre. Emerg Med Australas. 2007;19(4):359–65.PubMed
23.
Dubois S, Mullen N, Weaver B, Bédard M. The combined effects of alcohol and cannabis on driving: impact on crash risk. Forensic Sci Int. 2015;248:94–100.CrossRefPubMed
24.
Rudisill TM, Zhao S, Abate MA, Coben JH, Zhu M. Trends in drug use among drivers killed in U.S. traffic crashes, 1999-2010. Accid Anal Prev. 2014;70:178–87.CrossRefPubMedPubMedCentral
25.
Smith GW, Farrell M, Bunting BP, Houston JE, Shevlin M. Patterns of polydrug use in Great Britain: findings from a national household population survey. Drug Alcohol Depend. 2011;113(2–3):222–8.CrossRefPubMed
26.
Teeters JB, Pickover AM, Dennhardt AA, Martens MP, Murphy JG. Elevated alcohol demand is associated with driving after drinking among college student binge drinkers. Alcohol Clin Exp Res. 2014;38(7):2066–72.CrossRefPubMed
27.
Bogstrand ST, Gjerde H, Normann PT, Rossow I, Ekeberg Ø. Alcohol, psychoactive substances and non-fatal road traffic accidents--a case-control study. BMC Public Health. 2012;12:734.CrossRefPubMedPubMedCentral
28.
Gjerde H, Normann PT, Christophersen AS, Samuelsen SO, Mørland J. Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control study. Accid Anal Prev. 2011;43(3):1197–203.CrossRefPubMed
29.
Li G, Brady JE, Chen Q. Drug use and fatal motor vehicle crashes: a case-control study. Accid Anal Prev. 2013;60:205–10.CrossRefPubMed
30.
Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. J Adolesc Health. 2013;52(2):158–63.CrossRefPubMed
31.
Olfson M, Wall MM, Liu SM, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry. 2018;175(1):47–53.CrossRefPubMed
32.
Wu LT, Woody GE, Yang C, Blazer DG. Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2010;112(1–2):69–80.CrossRefPubMedPubMedCentral
33.
Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JR, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int. 2003;134(2–3):154–62.CrossRefPubMed
34.
Bezemer KD, Smink BE, van Maanen R, Verschraagen M, de Gier JJ. Prevalence of medicinal drugs in suspected impaired drivers and a comparison with the use in the general Dutch population. Forensic Sci Int. 2014;241:203–11.CrossRefPubMed
35.
Dischinger P, Li J, Smith GS, Ho S, Auman K, et al. Prescription medication usage and crash culpability in a population of injured drivers. Ann Adv Automot Med. 2011;55:207–16.PubMedPubMedCentral
36.
37.
Caetano R, McGrath C. Driving under the influence (DUI) among U.S. ethnic groups. Accid Anal Prev. 2005;37(2):217–24.CrossRefPubMed
38.
Hingson RW, Heeren T, Edwards EM. Age at drinking onset, alcohol dependence, and their relation to drug use and dependence, driving under the influence of drugs, and motor-vehicle crash involvement because of drugs. J Stud Alcohol Drugs. 2008;69(2):192–201.CrossRefPubMed
39.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed text rev. Washington, DC: American Psychiatric Association; 2000.
40.
Chou SP, Dawson DA, Stinson FS, Huang B, Pickering RP, et al. The prevalence of drinking and driving in the United States, 2001-2002: results from the national epidemiological survey on alcohol and related conditions. Drug Alcohol Depend. 2006;83(2):137–46.CrossRefPubMed
41.
42.
Shults RA, Kresnow MJ, Lee KC. Driver- and passenger-based estimates of alcohol-impaired driving in the U.S., 2001-2003. Am J Prev Med. 2009;36(6):515–22.CrossRefPubMed
43.
Font-Ribera L, Garcia-Continente X, Pérez A, Torres R, Sala N, et al. Driving under the influence of alcohol or drugs among adolescents: the role of urban and rural environments. Accid Anal Prev. 2013;60:1–4.CrossRefPubMed
44.
Barrio G, Pulido J, Bravo MJ, Lardelli-Claret P, Jiménez-Mejías E, de la Fuente L. An example of the usefulness of joinpoint trend analysis for assessing changes in traffic safety policies. Accid Anal Prev. 2015;75:292–7.CrossRefPubMed
45.
Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398–424.CrossRefPubMed
46.
47.
Subbaraman MS, Kerr WC. Support for marijuana legalization in the US state of Washington has continued to increase through 2016. Drug Alcohol Depend. 2017;175:205–9.CrossRefPubMedPubMedCentral
48.
Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood). 2016;35(7):1324–32.CrossRef
49.
Pardo B. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction. 2017;112(10):1773–83.CrossRefPubMed
50.
Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med. 2012;13(3):434–42.CrossRefPubMed
51.
Garnier LM, Arria AM, Caldeira KM, Vincent KB, O'Grady KE, et al. Nonmedical prescription analgesic use and concurrent alcohol consumption among college students. Am J Drug Alcohol Abuse. 2009;35(5):334–8.CrossRefPubMedPubMedCentral
52.
Anderson MD, Hansen B, Rees DI. Marijuana laws, traffic fatalities, and alcohol consumption. J Law Econ. 2013;56:333–63.CrossRef
53.
Anderson DM, Rees DI. The legalization of recreational marijuana: how likely is the worst-case scenario? J Policy Anal Manage. 2014 Winter;33(1):221–32.CrossRefPubMed
54.
Salomonsen-Sautel S, Min SJ, Sakai JT, Thurstone C, Hopfer C. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 2014;140:137–44.CrossRefPubMedPubMedCentral
55.
McCabe SE, Cranford JA, Boyd CJ. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample. Drug Alcohol Depend. 2006;84(3):281–8.CrossRefPubMedPubMedCentral
56.
Bogstrand ST, Gjerde H. Which drugs are associated with highest risk for being arrested for driving under the influence? A case-control study. Forensic Sci Int. 2014;240:21–8.CrossRefPubMed
57.
Linkenbach J, Perkins HW. Montana's MOST of us Don't drink and drive campaign: a social norms strategy to reduce impaired driving among 21–34 year olds. National highway traffic safety administration. Washington, DC; 2005. Final Report
58.
Perkins HW, Linkenbach JW, Lewis MA, Neighbors C. Effectiveness of social norms media marketing in reducing drinking and driving: a statewide campaign. Addict Behav. 2010;35(10):866–74.CrossRefPubMedPubMedCentral
59.
Moore AA, Gould R, Reuben DB, Greendale GA, Carter MK, et al. Longitudinal patterns and predictors of alcohol consumption in the United States. Am J Public Health. 2005;95(3):458–65.CrossRefPubMedPubMedCentral
60.
Osilla KC, Kulesza M, Miranda J. Bringing alcohol treatment to driving under the influence programs: perceptions from first-time offenders. Alcohol Treat Q. 2017;35(2):113–29.CrossRefPubMedPubMedCentral
61.
Schermer CR, Moyers TB, Miller WR, Bloomfield LA. Trauma center brief interventions for alcohol disorders decrease subsequent driving under the influence arrests. J Trauma. 2006;60(1):29–34.CrossRefPubMed
62.
Voas RB, DuPont RL, Talpins SK, Shea CL. Towards a national model for managing impaired driving offenders. Addiction. 2011;106(7):1221–7.CrossRefPubMed
63.
Terry-McElrath YM, O'Malley PM, Johnston LD. Alcohol and marijuana use patterns associated with unsafe driving among U.S. high school seniors: high use frequency, concurrent use, and simultaneous use. J Stud Alcohol Drugs. 2014;75(3):378–89.CrossRefPubMedPubMedCentral
64.
Wells-Parker E, Williams M. Enhancing the effectiveness of traditional interventions with drinking drivers by adding brief individual intervention components. J Stud Alcohol. 2002;63(6):655–64.CrossRefPubMed
Metadata
Title
Trends and correlates of driving under the influence of alcohol among different types of adult substance users in the United States: a national survey study
Authors
Ji-Yeun Park
Li-Tzy Wu
Publication date
01-12-2019
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6889-8

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue

Research article

Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial

Research article

Participant retention in follow-up studies of prematurely born children

Research article

Inequitable coverage of vitamin A supplementation in Nigeria and implications for childhood blindness

Research article

Associations of socioeconomic and religious factors with health: a population-based, comparison study between China and Korea using the 2010 East Asian social survey

Research article

Barriers and facilitators to adoption, implementation and sustainment of obesity prevention interventions in schoolchildren– a DEDIPAC case study

Research article

The association of mobility disability and obesity with risk of unemployment in two cohorts from Sweden